To assess the prevalence, demography, and clinical features of liver disease among patients with cystic fibrosis the case notes of 524 patients of ali ages who were attending the cystic fibrosis clinic were studied. Computer databases were used to establish the condition of the liver in a further 576 such patients. The overall prevalence of overt liver disease indicated by the presence of an enlarged liver or spleen (or both) was 4-2%. The age related prevalence rose to a peak in adolescence, and then feli in patients over 20 years old. The implied increase in mortality among those with liver disease was not explained by deaths from liver disease, which were rare. Male patients were significantly more affected than female, the ratio being 3:1 among adolescents. Increasing prevalence of liver disease in patients with cystic fibrosis is, therefore, not just a result of longevity.
Liver cirrhosis was recognised as a complication of cystic fibrosis in Andersen's original description in 1938, but until recently the importance of subclinical liver disease has been eclipsed by the more obvious respiratory and pancreatic signs and symptoms. ' More effective management of these has resulted in greatly improved survival, and so liver disease has become important to a larger number of patients.
The aetiology of focal biliary cirrhosis in cystic fibrosis is uncertain,3 but poor nutrition,4 inspissated bile,5 autoimmunity,6 and biliary tract obstruction7 8 have all been suggested.
Previous estimates of prevalence varied depending on the diagnostic criteria used.9 1o If cross sectional necropsy data are combined it looks as if prevalence rises steadily with age.5 12 There has been no study of clinically important liver disease in a large group of patients with cystic fibrosis spanning the entire age range.
A number of authors have shown that liver function tests are disordered in a high proportion of patients with cystic fibrosis and liver impairment, but that the degree of abnormality does not correlate with the extent of cirrhosis.5 [13] [14] [15] [16] Some patients with obvious liver disease have normal test results, and there is a large number whose results are abnormal and whose true liver condition is uncertain.9 10 Patients and methods The casenotes of all 524 patients attending adult and paediatric specialist cystic fibrosis clinics in four midlands centres (Birmingham, Nottingham, Peterborough, and Leicester) were reviewed. Subsequently the computer records of 576 patients with cystic fibrosis who were attending clinics in three northern centres (Manchester, Liverpool, and Leeds) were surveyed. All those with possible clinical evidence of liver disease were identified, and their casenotes were then examined. All the patients had undergone repeated abdominal examinations by physicians experienced in treating cystic fibrosis during routine visits to the clinic. From the records the presence of an enlarged liver or spleen (or both) was noted. If a spleen was described as 'palpable' it was considered to be enlarged. The 11. Of these, all had enlarged spleens, and six had bled at least once. There was no variceal bleeding in patients who did not have enlarged spleens. Six of 46 in the combined clinical group (13-0%) had liver enzyme activities within the reference ranges, and four also had enlarged spleens.
No patient had jaundice or ascites at the time of the study.
The prevalence of abnormal liver enzyme activities in the absence of clinical disease could be estimated only for the midlands group of 524: 50 were identified (9-5%). These represented 12 9% of those who had had liver enzymes measured.
Clinically apparent and radiologically proved biliary disease was rare and restricted to the older age groups. Only six patients out of 1100 (0-55%) were found: one of 183 (0-5%) in the 16-20 age band, three of 107 (2 8%) in the 21-25 band, and two of 38 (4-6%) aged over 25 years.
AGE RELATED PREVALENCE (table 1) There was a progressive rise in the prevalence of clinically apparent liver disease from 0-3% in the 0-5 age group to a peak of 8-7% among those aged [16] [17] [18] [19] [20] . Thereafter, instead of the expected progressive rise, there was a fall to only 4-1% among 145 patients over 20 years of age. The same trend was seen when only those with splenomegaly were considered, or when those who had neither an enlarged spleen nor abnormal liver function tests were excluded.
The group with portal hypertension as indicated by an enlarged spleen had a mean age of 15-3 years (range 7-27), and those with oesophageal varices had a mean age of 17-3 years (range 9-27).
Biochemical abnormalities without clinical signs were more prevalent than overt disease (table 2) , and showed a similar although less pronounced peak, rising to 16-0% in the 16-20 age group, and falling to 11-5% over 20.
SEX RELATED PREVALENCE
Significantly more male patients were affected by clinical disease, both in the midlands and in the combined populations; 33/605 (5-4%) were affected overall compared with 13/495 (2-6%) of female patients, (p<005). The difference was seen at all ages over 5 years, and was most pronounced in the 11-15 age group, in which three times as many boys as girls were affected. There were no significant differences between the sexes in the group with biochemical abnormalities only, but prevalence data for this group Thus the assumption of a rising prevalence of liver disease with age in cystic fibrosis is based 23 mainly on necropsy series. In the present study the prevalence of clinically overt disease in 1100 patients with cystic fibrosis was 4-4%, similar to some quoted estimates.'0 23 This is likely to be an underestimate of the true prevalence of focal biliary cirrhosis, as the histopathological changes may precede enlargement of the liver or the development of portal hypertension.
The presence of an enlarged liver in isolation, with no other evidence of liver disease, should be interpreted with caution because this may be the result of depression of a normal liver below the costal margin by hyperinflated lungs, rather than true enlargement. Measuring the liver span by percussion is difficult in patients with cystic fibrosis because the chest is frequently hyperresonant throughout. In our series, however, only four patients had isolated liver enlargement with neither splenomegaly nor abnormal liver function tests, and when these were excluded the same trends in age and sex prevalence were seen.
Liver disease was relatively uncommon before the age of 10 years. Some of the younger patients may have had hepatic steatosis related to poor nutrition rather than cirrhosis.24 Thereafter, instead of the expected progressive rise into adult life, there was a peak during adolescence followed by a fall in prevalence over the age of 20 years.
There are two possible explanations for this observation. Firstly, it may be an unexplained cohort effect, and further longitudinal studies would show whether the prevalence peak shifts into adult life. Alternatively, because liver disease in cystic fibrosis is irreversible, this trend can be explained by an increase in mortality in the teenage years among those with liver disease. Our review of mortality records for the preceding 10 years showed that only 7-8% of deaths could be attributed directly to liver disease, either hepatocellular failure or portal hypertension. It Subclinical biliary disease is thought to be common among adults with cystic fibrosis. In one study 17 of 23 adults with abnormal liver enzyme activities had abnormalities on biliary imaging,'8 and this was suggested to be the primary hepatobiliary lesion in cystic fibrosis.7 We found symptoms of biliary disease to be rare.
The mode of presentation of liver disease was by routine abdominal examination in most patients, and in only two of 46 of the clinical group (4%) was the development of overt disease predicted by abnormal liver function tests. We found no strong evidence of familial concordance as reported by Schuster et al. 26 As expected, 20% of those with overt disease had oesophageal varices although, because not all patients had been recently investigated, the true incidence may have been higher. Enlargement of the spleen seems to predict those at risk from haemorrhage.
In conclusion, these data suggest that the prevalence of liver disease in cystic fibrosis peaks during adolescence, affects male more than female patients, and seems to be associated with earlier death. Those with liver disease may thus form an identifiable group with a worse prognosis who warrant more aggressive treatment. Poor nutritional state associated with liver disease may contribute to the shorter life span, but data are lacking. Clinical signs are probably a late sign of liver disease, but results of liver function tests are unreliable. The cause, future changes in prevalence, and the prognosis of liver disease in cystic fibrosis demand further study.
